Could biologic injectables change the eczema trajectory?
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Could biologic injectables change the eczema trajectory?
-
Narrado por:
-
De:
Acerca de esta escucha
Could injectable drugs called "biologics" stop eczema by teaching a child's developing immune system to be less reactive? Dr. Amy Paller from Northwestern University Chicago and Dr. Elaine Siegfried from Saint Louis University in Missouri discuss stopping or tapering biologics and what happens to the immune system when we are on them. If you like our podcast, please consider supporting it with a tax deductible donation.
Research discussed
Clinical remission and therapy-free remission in pediatric patients with moderate-to-severe atopic dermatitis treated with dupilumab
Factors Associated with Remission of Eczema in Children
Persistence of Mild to Moderate Atopic Dermatitis
Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children